Cargando…
Harnessing the immune system in the treatment of cutaneous T cell lymphomas
Cutaneous T cell lymphomas are a rare subset of non-Hodgkin’s lymphomas with predilection for the skin with immunosuppressive effects that drive morbidity and mortality. We are now appreciating that suppression of the immune system is an important step in the progression of disease. It should come a...
Autores principales: | Fay, Christopher J., Awh, Katherine C., LeBoeuf, Nicole R., Larocca, Cecilia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878398/ https://www.ncbi.nlm.nih.gov/pubmed/36713518 http://dx.doi.org/10.3389/fonc.2022.1071171 |
Ejemplares similares
-
Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature
por: Song, Johanna S., et al.
Publicado: (2017) -
Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
por: Fay, Christopher J., et al.
Publicado: (2023) -
An Update on Molecular Biology of Cutaneous T Cell Lymphoma
por: Walia, Ritika, et al.
Publicado: (2020) -
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
por: Zhang, Ping, et al.
Publicado: (2021) -
Advances in the understanding and treatment of Cutaneous T-cell Lymphoma
por: Bakr, Farrah S., et al.
Publicado: (2022)